At best this is poor journalism, at worst it's some kind of paid placement. They make a claim that it's safe to use concurrently with medication, refer to comp

At best this is poor journalism, at worst it's some kind of paid placement. They make a claim that it's safe to use concurrently with medication, refer to company employees as "according to the experts". The say it's a clear breakthrough and safe. Here is a proper article on the result, explaining the good and the bad, for example that there was no benefit for patients with moderate disease: http://www.medscape.com/viewarticle/873886 http://www.medscape.com/viewarticle/873886